Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
W Ni, X Yang, D Yang, J Bao, R Li, Y **ao, C Hou… - Critical Care, 2020 - Springer
An outbreak of pneumonia caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that started in Wuhan, China, at the end of 2019 has become a global …
(SARS-CoV-2) that started in Wuhan, China, at the end of 2019 has become a global …
Biomarkers associated with COVID-19 disease progression
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
Y Liu, Y Yang, C Zhang, F Huang, F Wang… - Science China Life …, 2020 - Springer
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei
province, and rapidly spread to many provinces in China as well as other countries. Here we …
province, and rapidly spread to many provinces in China as well as other countries. Here we …
[HTML][HTML] Human recombinant soluble ACE2 in severe COVID-19
A Zoufaly, M Poglitsch, JH Aberle… - The Lancet …, 2020 - thelancet.com
Human recombinant soluble ACE2 in severe COVID-19 - The Lancet Respiratory Medicine Skip
to Main Content Advertisement The Lancet Respiratory Medicine Submit Article Log in Register …
to Main Content Advertisement The Lancet Respiratory Medicine Submit Article Log in Register …
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Y Yang, C Shen, J Li, J Yuan, J Wei, F Huang… - Journal of Allergy and …, 2020 - Elsevier
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
The genetic sequence, origin, and diagnosis of SARS-CoV-2
H Wang, X Li, T Li, S Zhang, L Wang, X Wu… - European Journal of …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a new infectious disease that first emerged in …
syndrome coronavirus 2 (SARS-CoV-2), is a new infectious disease that first emerged in …
COVID-19, ACE2, and the cardiovascular consequences
The novel SARS coronavirus SARS-CoV-2 pandemic may be particularly deleterious to
patients with underlying cardiovascular disease (CVD). The mechanism for SARS-CoV-2 …
patients with underlying cardiovascular disease (CVD). The mechanism for SARS-CoV-2 …
Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation
The COVID‐19 coronavirus is now spreading worldwide. Its pathogen, SARS‐CoV‐2, has
been shown to use angiotensin‐converting enzyme 2 (ACE2) as its host cell receptor, same …
been shown to use angiotensin‐converting enzyme 2 (ACE2) as its host cell receptor, same …
[HTML][HTML] Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients
Summary The coronavirus disease 2019 (COVID-19) pandemic poses a current world-wide
public health threat. However, little is known about its hallmarks compared to other infectious …
public health threat. However, little is known about its hallmarks compared to other infectious …
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19,
utilizes angiotensin-converting enzyme 2 (ACE2) for entry into target cells. ACE2 has been …
utilizes angiotensin-converting enzyme 2 (ACE2) for entry into target cells. ACE2 has been …